Entering text into the input field will update the search result below

Repros Therapeutics beats by $0.02

  • Repros Therapeutics (NASDAQ:RPRX): Q1 EPS of -$0.20 beats by $0.02.
  • Revenue of $17K
  • Press Release

Recommended For You

More Trending News

About RPRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RPRX--
Royalty Pharma plc